Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel)
Lucid Diligence Brief: Gilead to acquire Arcellx (anito-cel) Professional…
Hematology Today—February 9, 2026
This weekly Hematology update covers regulatory actions, clinical trial…
Hematology Today—February 2, 2026
This weekly update in Hematology covers regulatory actions, late-stage clinical…
Hematology Video Recap—January 26, 2026
This biweekly hematology video covers regulatory actions, clinical progress in…
Hematology Today—January 26, 2026
A focused weekly roundup of hematology and cell-therapy developments, covering…
Hematology Video Recap—January 12, 2026
This hematology video covers major regulatory and guideline milestones across…
Hematology Today—January 12, 2026
This week’s Hematology update spotlights key developments, regulatory…
Hematology Today—January 5, 2026
This hematology roundup brings together major regulatory decisions, global…
Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic
Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic…
Hematology Video Recap—December 15, 2025
This biweekly hematology update covers major regulatory decisions, late-stage…
Hematology Today—December 15, 2025
This week’s hematology update spotlights key developments, regulatory…
Hematology Today—December 8, 2025
This week in Hematology, we spotlight the most relevant updates, approvals, and…